Subscribe: MedWorm: Biotechnology
http://www.medworm.com/rss/medicalfeeds/specialities/Biotechnology.xml
Preview: MedWorm: Biotechnology

MedWorm: Biotechnology News



MedWorm.com provides a medical RSS filtering service. Thousands of medical RSS feeds are combined and output via different filters. This feed contains the latest news in Biotechnology



Last Build Date: Tue, 20 Feb 2018 18:29:43 +0100

 



Cambridge's Voyager, AbbVie to pursue Alzheimer's gene therapy under $69M deal

Tue, 20 Feb 2018 15:52:28 +0100

Voyager Therapeutics said Tuesday that it will work with AbbVie to develop gene therapy treatments for Alzheimer ’s disease in a deal worth at least $69 million for the Cambridge biotech. The announcement by Voyager (Nasdaq: VYGR) and Chicago-based AbbVie (NYSE: ABBV) comes as drug developers are exploring new approaches to Alzheimer’s following a string of recent clinical setbacks. Gene therapies — dru gs that work by inserting healthy genes into a person’s cells to replace faulty or missing… (Source: bizjournals.com Health Care News Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Private hospitals making up to 1,737% profit on drugs, finds NPPA study

Tue, 20 Feb 2018 13:38:16 +0100

NPPA's study found that "the major beneficiaries of profits in all these cases because of inflated MRPs have been hospitals rather than drug manufacturers ”. (Source: The Economic Times Healthcare and Biotech News)



Merck and three partners start ExploreBio, a € 20 million pre-seed investment initiative in Israel

Tue, 20 Feb 2018 11:00:00 +0100

Merck, a leading science and technology company, today announced ExploreBio, a pre-seed-investment vehicle by four investment funds targeted at early-stage companies in the biotechnology landscape in Israel. For this purpose the strategic corporate venture capital arm of Merck has partnered with Arkin Holdings, Pontifax and WuXi AppTec to create the € 20 million pre-seed investment vehicle. (Source: World Pharma News)



Paul Hastings lands at startup aimed at cancer's 'natural killer'

Tue, 20 Feb 2018 07:07:56 +0100

Paul Hastings starts Tuesday at Nkarta Therapeutics, a South San Francisco startup focused on harnessing "natural killer" cells in the immune system to defeat cancer. (Source: bizjournals.com Health Care:Biotechnology headlines)



Behind the Scenes: ADAPT Shop meets the needs of disabled children

Tue, 20 Feb 2018 03:00:03 +0100

The ADAPT Shop is a unique workshop where young children with significant physical disabilities and their families have access to equipment specialists and receive custom-made adapted technologies to help them learn, play and grow. Products fabricated at ADAPT, such as custom-made seating or mobile scooters, help children develop the competence, confidence and self-esteem they need to become independent. Since opening in 2011, the ADAPT Shop has served nearly 600 children with disabilities and… (Source: bizjournals.com Health Care:Biotechnology headlines)



Taking the Reins: How Patrick Conway is ready to shake things up at Blue Cross Blue Shield of North Carolina

Mon, 19 Feb 2018 20:12:11 +0100

On an unusually warm morning on Feb. 12, Dr. Patrick Conway, the newly minted CEO of Blue Cross and Blue Shield of North Carolina, was speaking to a group of business executives about health care at North Ridge Country Club in Raleigh. (Source: bizjournals.com Health Care:Biotechnology headlines)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Maryland Hospital Association taps new CEO

Mon, 19 Feb 2018 19:17:47 +0100

Bob Atlas, a health care industry veteran and policy adviser, has been selected to lead the Maryland Hospital Association as its new president and CEO. Atlas was selected by the association's executive committee through a national search. He will be the fourth president in the MHA’s 48-year history. He succeeds Carmela Coyle, who left MHA after nine years, to take the reins at the California Hospital Association. Currently president of EBG Adv isors, the consulting affiliate of the health law… (Source: bizjournals.com Health Care:Biotechnology headlines)



Catholic Health names Sullivan as new CEO

Mon, 19 Feb 2018 16:35:27 +0100

Catholic Health has named a longtime executive as its new CEO: Mark Sullivan will assume the post on March 1, moving up from executive vice president and chief operating officer. The appointment recognizes Sullivan’s tenure in the No. 2 role under Joe McDonald, who announced his retirement in September. He was selected from among 30 applicants following a national search. William Buscaglia Jr., board chair since 2015, said selecting someone from within provides a stabil izing influence. “He… (Source: bizjournals.com Health Care:Biotechnology headlines)



Seattle-based Biller Family Foundation donates $1 million to cancer-research hospital

Mon, 19 Feb 2018 15:32:46 +0100

This gift will help educate doctors and nurses across the country on the benefits of supportive services that address the psychological, spiritual and social needs of cancer patients and their families. (Source: bizjournals.com Health Care:Biotechnology headlines)



St. Jude to build $412M 'linchpin' advanced research center

Mon, 19 Feb 2018 15:05:25 +0100

St.  Jude Children's Research Hospital is creating a $412 million research center, the largest project ever on the Memphis hospital's campus.  The center, slated to break ground this spring and open in 2021, is a major component of the hospital's previously announced $1 billion campus expansion — itself a piece of a $7 billion spend to expand the hospital's efforts to cure childhood diseases. The 625,000-square-foot, eight-story center is designed to attract the best scientists and clinicians from… (Source: bizjournals.com Health Care:Biotechnology headlines)



Plans for $22.5M nursing home, pediatric heart transplant program denied by state

Mon, 19 Feb 2018 14:36:02 +0100

Arnold Palmer Medical Center's $1.5 million plan gets turned down. (Source: bizjournals.com Health Care:Biotechnology headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Startup draws $3 million investment from Japanese biotech firm

Mon, 19 Feb 2018 11:05:00 +0100

Unleash Immuno Oncolystics founder Daniel Curiel said the biotech industry is at a "tipping point" with established companies adopting the new technology. (Source: bizjournals.com Health Care:Biotechnology headlines)



Act now to find heart disease before it finds you

Mon, 19 Feb 2018 08:34:37 +0100

According to the Centers for Disease Control and Prevention, heart disease is the leading cause of death for both men and women. But that doesn ’t mean the men and women of Southwest Ohio have to wonder about their risk or how to reduce it. Heart attacks happen suddenly, disrupting and devastating families in an instant. However, they are the result of internal blockages that can take years to develop. Although heart disease rarely revea ls itself through symptoms in its earliest and most treatable… (Source: bizjournals.com Health Care:Biotechnology headlines)



Sonora Quest CEO David Dexter innovating for growth

Sun, 18 Feb 2018 21:36:50 +0100

Twenty years after starting, David Dexter is looking to improve on Sonora Quest. (Source: bizjournals.com Health Care:Biotechnology headlines)



Former Fortune 500 execs join Colorado health-tech firm focused on thwarting opioid abuse

Sun, 18 Feb 2018 18:29:30 +0100

Two former executives of Procter& Gamble Co., one of the nation's largest consumer-products companies, have joined the leadership team of Colorado-based Safe Rx LLC. Greenwood Village-based Safe RX makes prescription drug bottles with combination locks designed to thwart opioid abuse. Former P&G brand manager Andy Cipra has been hired as chief commercial officer of Safe Rx, and former P&G executive Rick Meckstroth has been hired as vice president of business development. Adding Cipra and Meckstroth… (Source: bizjournals.com Health Care:Biotechnology headlines)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Exclusive: Anthem sells Worthington office, prompting search for new space for 400 employees

Sun, 18 Feb 2018 12:35:13 +0100

Anthem is looking to move its local office from its long-time home in Worthington, leaving an opening in one of Central Ohio's largest suburban office buildings. (Source: bizjournals.com Health Care:Biotechnology headlines)



China ’s great leap forward in science

Sun, 18 Feb 2018 09:00:40 +0100

Chinese investment is paying off with serious advances in biotech, computing and space. Are they edging ahead of the west?I first met Xiaogang Peng in the summer of 1992 at Jilin University in Changchun, in the remote north-east of China, where he was a postgraduate student in the department of chemistry. He told me that his dream was to get a place at a top American lab. Now, Xiaogang was evidently smart and hard-working – but so, as far as I could see, were most Chinese science students. I wished him well, but couldn’t help thinking he’d set himself a massive challenge.Fast forward four years to when, as an editor atNature, I publish a paper on nanotechnology from world-leading chemists at the University of California at Berkeley. Among them was Xiaogang. That 1996 paper now appear...



How can I make money from my DNA?

Sun, 18 Feb 2018 07:30:38 +0100

If you have your DNA sequenced, someone somewhere will be making money from the data. A new start-up aims to make sure that you get your share• A share in the future of DNA: Prof George Church Q&AIf you unlock the secrets of your DNA by paying a company to read your genes, behind the scenes it is probably making money by selling on your data for research. Companies like23andMe andAncestryDNA charge consumers under £150 to learn about their health and/or origins, while others do whole genome sequencing for a little over £1,000 (although in the US it is cheaper at just under $1,000). The model works like this: send in a saliva sample, receive the results and provided you consent, which most people do because they want to help research efforts, the company retains control of the data....



Which cities are best for your health? Yes, Orlando is one of them

Sun, 18 Feb 2018 00:04:49 +0100

Many people set health goals, like eating healthier foods and getting more exercise, and the city they live in could play a role in their success. WalletHub ranked the healthiest cities in the U.S. measuring indicators of good health such as fruit and vegetable consumption, fitness clubs per capita, and the cost of doctors' visits. San Francisco came in first place and scored high in availability of healthy food and the amount of green spa ce in the area. Orlando was the top-ranked Florida metro,… (Source: bizjournals.com Health Care:Biotechnology headlines)



Rural WNY hospitals to receive $9 million from feds

Sat, 17 Feb 2018 13:07:03 +0100

New legislation at the federal level will provide rural hospitals with $9 million over the next five years, helping to relieve at least a little bit of funding uncertainty. The funds come through the extension of two programs that were included in the Bipartisan Budget Act of 2018. Both programs expired last October.  The Low-Volume Hospital (LVH) program provides funding to the rural hospitals deemed critical to the community but may not serve a high volume of pat ients. The Medicare-Dependent… (Source: bizjournals.com Health Care:Biotechnology headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




East Bay cancer drug developer targets $100 million IPO

Sat, 17 Feb 2018 01:51:17 +0100

Arcus Biosciences Inc., launched by scientists after the $1.25 billion buyout of their previous company, hopes to raise $100 million in an initial public offering to pursue an aggressive clinical trial schedule for drugs that help the immune system find and attack cancer. The 83-employee Hayward company's IPO filing Friday with the Securities and Exchange Commission said the cash will fund clinical development of its main drugs, called AB-928 and AB-122, and support other drug candidates and hire… (Source: bizjournals.com Health Care:Biotechnology headlines)



D.C. Council delays decision on UMC's new turnaround company

Fri, 16 Feb 2018 22:23:23 +0100

Seven D.C. Council members filed a resolution Friday that delays a decision on the pending $5 million turnaround contract proposed for District-owned United Medical Center. The move extends the long-struggling hospital's contract with its current operator, Veritas of Washington LLC. D.C. Council had voted in November to cut ties with Veritas over questions about the consultancy's performance after the D.C. Health Department forced the closure of UMC's obstetrics unit . But the seven members, including… (Source: bizjournals.com Health Care:Biotechnology headlines)



San Antonio medical offices among properties in 1.4M-square-foot portfolio sale

Fri, 16 Feb 2018 20:35:53 +0100

The Westover Hills Medical Plaza, which includes three medical offices, is among the properties within a 1.4 million-square-foot portfolio purchased recently by an affiliate of global real estate investment firm Heitman LLC. The three medical offices make up just over 200,000 square feet in the larger portfolio, which includes 17 buildings in seven states. Besides the Westover Hills Medical Plaza in San Antonio, which was last assessed by the Bexar County Appraisal District at roughly $33.5 million,… (Source: bizjournals.com Health Care:Biotechnology headlines)



United Therapeutics reaches patent settlement with Actavis

Fri, 16 Feb 2018 20:11:18 +0100

Silver Spring biotech United Therapeutics Corp.'s share price was largely unchanged Friday after announcing it settled litigation with Actavis Laboratories FL Inc. in a deal that will allow that company to market a generic version of one of United Therapeutics' hypertension drugs. Under the settlement, United Therapeutics (NASDAQ: UTHR) grants the Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) subsidiary a license to manufacture and commercialize a generic version of Orenitram — an extended-release,… (Source: bizjournals.com Health Care:Biotechnology headlines)



Novavax shares up big again. What's moving the needle?

Fri, 16 Feb 2018 20:11:11 +0100

Shares of Gaithersburg-based Novavax Inc. have spiked again, jumping by 18 percent during Friday trading, as the company is increasingly considered a promising acquisition target. On Friday afternoon — its third major spike so far this year — the company was trading at $2.43, up from an opening price of $2.06 and up 12.5 percent from its Thursday closing price of $2.16 per share. Trading volume reached 29.4 million shares, nearly triple the company's average volume of 1 0.2 million shares. The… (Source: bizjournals.com Health Care:Biotechnology headlines)



Comprehensive autism therapy clinic Hopebridge expanding in Ohio, bringing 1,000 jobs

Fri, 16 Feb 2018 20:11:04 +0100

A chain of clinics that offers a large range of therapies for autism under one roof – and insists on a one-to-one therapist-to-child ratio – is opening four to five centers in Central Ohio within a year as part of a 20-site expansion to the state. Hopebridge LLC said it will bring 1,000 jobs to Ohio. Founded in 2005, the Indianapolis company has 16 centers in Indiana and Kentu cky. “There’s a tremendous need, a tremendous shortage of access to care for children on the spectrum," CEO Dennis… (Source: bizjournals.com Health Care:Biotechnology headlines)



Jupiter Medical Center seeks approval for major expansion plan

Fri, 16 Feb 2018 19:57:25 +0100

The hospital hopes to break ground this year. (Source: bizjournals.com Health Care:Biotechnology headlines)



We now know how much Sucampo founders made from the company's sale

Fri, 16 Feb 2018 19:44:01 +0100

New regulatory filings were disclosed this week after Sucampo Pharmaceuticals closed on its $1.2 billion sale to Mallinckrodt. (Source: bizjournals.com Health Care:Biotechnology headlines)



North Tonawanda man pleads guilty to $45M health care billing scheme

Fri, 16 Feb 2018 19:30:27 +0100

A North Tonawanda man has pled guilty in a $45 million fraud case related to unnecessary compounded medications. Steven Butcher pleaded guilty before U.S. District Judge John Michael Vazquez in a Newark, New Jersey federal court to charges of conspiracy to commit health care fraud and violations of the anti-kickback statute. According to the New Jersey U.S. Attorney’s Office, Butcher was formerly a pharma ceutical sales representative who went on to become owner/operator of MedMax LLC, a marketing… (Source: bizjournals.com Health Care:Biotechnology headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




United Therapeutics settles patent litigation over $157M drug

Fri, 16 Feb 2018 19:25:31 +0100

United Therapeutics has settled patent litigation over a $157 million drug. The company (Nasdaq: UTHR) reached an agreement with Actavis Laboratories FL, which is a subsidiary of generic giant Teva Pharmaceuticals, that resolves litigation over certain patents related to one of United Therapeutics' pulmonary arterial hypertension drugs: Orenitram. United Therapeutics repo rted upward of $157 million in revenue from Orenitram in 2016, with total revenue at roughly $1.6 billion.  The settlement… (Source: bizjournals.com Health Care:Biotechnology headlines)



Why an OHSU doctor wants his colleagues to know more about joints, blunts and spliffs

Fri, 16 Feb 2018 14:35:40 +0100

Dr. Jeramy Peters wrote a primer for clinicians on "routes of cannabis consumption." (Source: bizjournals.com Health Care:Biotechnology headlines)



Portland health IT startup enlists two major health systems for broad rollouts

Fri, 16 Feb 2018 14:17:39 +0100

Providence Health& Services is making Bright.md ’s virtual care platform available to all of the health system’s primary care patients in Oregon, representing another leap forward for the Portland health IT startup. Another major health system, Presbyterian Healthcare Services, is also making SmartExam available to its patients in New Mexico , Bright.md announced. And Presbyterian will be the first to introduce Bright.md’s new medically certified Spanish translation services in New Mexico,… (Source: bizjournals.com Health Care:Biotechnology headlines)



Because of Glick, the world comes to Jericho Road

Fri, 16 Feb 2018 14:00:00 +0100

Dr. Myron Glick grew up abroad in a missionary family. Now refugees and immigrants from across the world come to him in his role as chief medical officer at Jericho Road Community Health Center in Buffalo. (Source: bizjournals.com Health Care:Biotechnology headlines)



Which cities are best for your health?

Fri, 16 Feb 2018 13:46:50 +0100

Many people set health goals, like eating healthier foods and getting more exercise, and the city they live in could play a role in their success. WalletHub ranked the healthiest cities in the U.S. measuring indicators of good health such as fruit and vegetable consumption, fitness clubs per capita, and the cost of doctors' visits. San Francisco came in first place and scored high in availability of healthy food and the amount of green spa ce in the area. Here are the cities ranked behind San… (Source: bizjournals.com Health Care:Biotechnology headlines)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




She's finding patients' families a place to stay

Fri, 16 Feb 2018 13:16:59 +0100

Participants are not charged for staying with a host, and compared to what it would cost to board in a hotel, they are saving up to $1,000 or more per stay. (Source: bizjournals.com Health Care:Biotechnology headlines)



Here's how much Gaithersburg's Emergent BioSolutions execs will take home in cash bonuses

Fri, 16 Feb 2018 13:16:58 +0100

The biotech company just completed a busy year. (Source: bizjournals.com Health Care:Biotechnology headlines)



Ascension acquires Illinois health system

Fri, 16 Feb 2018 13:11:11 +0100

Ascension and Presence Health singed a letter of intent about the merger in August. (Source: bizjournals.com Health Care:Biotechnology headlines)



Abbott Northwestern plans $29M neuroscience unit

Fri, 16 Feb 2018 13:05:10 +0100

Abbott Northwestern Hospital is planning to build a $29.2 neuroscience unit within the next two years, becoming the latest Twin Cities health provider to place a big bet on a growing market for the medical field. The Star Tribune reports on the plan by Minneapolis-based Abbott Northwestern, which is owned by Allina Health System. Allina would provide most of the funding for the new unit, with about $7.5 million coming through other nonprofits. The project, which would include 56 inpatient beds,… (Source: bizjournals.com Health Care:Biotechnology headlines)



Why this big biotech player is leaving San Francisco's Mission Bay for the Peninsula

Fri, 16 Feb 2018 13:05:04 +0100

A new Peninsula campus will consolidate some 400 employees in one place and give more space to the startup companies it helps. (Source: bizjournals.com Health Care:Biotechnology headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Extra-Large Employer No. 1: Humana helps workers realize health dreams

Fri, 16 Feb 2018 11:45:00 +0100

Humana ’s efforts and results lead the company to achieve 2017 Healthiest Employer in the Extra-Large Company category. (Source: bizjournals.com Health Care:Biotechnology headlines)



SC rejects petition by Singh brothers against Daiichi's arbitration award

Fri, 16 Feb 2018 06:34:39 +0100

Daiichi approached the high court earlier this week to enforce the award following this favourable judgment. (Source: The Economic Times Healthcare and Biotech News)



The next big thing in Buffalo biotech? Answer may be OmniSeq.

Fri, 16 Feb 2018 06:07:00 +0100

OmniSeq is starting to turn its potential into real momentum, and leaders are starting to talk about a future with major rounds of private fundraising or an IPO. (Source: bizjournals.com Health Care:Physician Practices headlines)



40 Under Forty: Joe Meador

Fri, 16 Feb 2018 03:34:04 +0100

The craziest thing he's done? I asked my wife-to-be to marry me after dating for only three months. At the time, it didn ’t feel crazy. We’ve been married now for 15 years and couldn’t be happier! (Source: bizjournals.com Health Care:Biotechnology headlines)



2018 Health Care Heroes finalist: Abby Bradburn

Fri, 16 Feb 2018 02:00:00 +0100

Abby Bradburn is a registered nurse manager of health services for Ohio Valley Goodwill Industries. (Source: bizjournals.com Health Care:Biotechnology headlines)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




2018 Health Care Heroes winner: Linda Robinson

Fri, 16 Feb 2018 02:00:00 +0100

Linda Robinson is manager of innovation and process transformation for St. Elizabeth Healthcare. (Source: bizjournals.com Health Care:Biotechnology headlines)



2018 Health Care Heroes finalist: Dr. Dustin Calhoun

Fri, 16 Feb 2018 02:00:00 +0100

Emergency medicine physican University of Cincinnati College of Medicine/UC Health Calhoun helped develop Pytensys, a customized, mobile trauma response kit.  What inspired the Pytensys system? Large mass casualty incidents are relatively rare events, fortunately, which require a significant amount of resources and planni ng to mitigate. A local company, TyTek Industries, was working with a large venue organizer to develop a self-contained, mobile disaster medical resource system. They approached… (Source: bizjournals.com Health Care:Biotechnology headlines)



2018 Health Care Heroes finalist: Dr. John Brannan

Fri, 16 Feb 2018 02:00:00 +0100

Dr. John Brannan is a physiatrist with Beacon Orthopaedics and Sports Medicine. (Source: bizjournals.com Health Care:Biotechnology headlines)



2018 Health Care Heroes finalist: Dr. Michael Greiwe

Fri, 16 Feb 2018 02:00:00 +0100

Dr. Michael Greiwe is an orthopedic surgeon with OrthoCincy and founder of OrthoLive. (Source: bizjournals.com Health Care:Biotechnology headlines)



2018 Health Care Heroes finalist: Dr. Manish Srivastava

Fri, 16 Feb 2018 02:00:00 +0100

Dr. Manish Srivastava is medical director of TriHealth Palliative Medicine and Hospice of Cincinnati. (Source: bizjournals.com Health Care:Biotechnology headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




2018 Health Care Heroes finalist: Timothy Cappel

Fri, 16 Feb 2018 02:00:00 +0100

Timothy Cappel is executive director of the clinically integrated network (CIN) and population health at Christ Hospital Health Network. (Source: bizjournals.com Health Care:Biotechnology headlines)



2018 Health Care Heroes finalist: Mary Schmidt

Fri, 16 Feb 2018 02:00:00 +0100

Mary Schmidt is a health advocate nurse at the Newport Aquarium. (Source: bizjournals.com Health Care:Biotechnology headlines)



2018 Health Care Heroes finalist: Mary Pat Gilligan

Fri, 16 Feb 2018 02:00:00 +0100

Mary Pat Gilligan is executive director of perioperative nursing for TriHealth. (Source: bizjournals.com Health Care:Biotechnology headlines)



Why this big biotech player is leaving Mission Bay for the Peninsula

Thu, 15 Feb 2018 22:33:49 +0100

A new Peninsula campus will consolidate some 400 employees in one place and give more space to the startup companies it helps. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)



Icon reports more expectation-beating results

Thu, 15 Feb 2018 18:39:04 +0100

Medtech, pharma and biotech development outsourcer Icon continues to beat the Street when it comes to its results. Dublin, Ireland–based Icon (Nasdaq:ICLR) said today that it earned $78.5 million, or $1.43 per share, off $455.1 million in sales for the fourth quarter ended Dec. 31, 2017 – up from $74.3 million, or $1.33 per share, in profits off $435.1 million in revenue for the same quarter a year before. Analysts on average had expected fourth-quarter profits of $1.42 per share off $454.6 million in revenue, according to Yahoo Finance. Get the full story on our sister site Medical Design & Outsourcing. The post Icon reports more expectation-beating results appeared first on MassDevice. (Source: Mass Device)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




FDA Approves First Blood Test to Help Diagnose Brain Injuries

Thu, 15 Feb 2018 17:23:37 +0100

(CHICAGO) — The first blood test to help doctors diagnose traumatic brain injuries has won U.S. government approval. The move means Banyan Biomarkers can commercialize its test, giving the company an early lead in the biotech industry’s race to find a way to diagnose concussions. The test doesn’t detect concussions and the approval won’t immediately change how patients with suspected concussions or other brain trauma are treated. But Wednesday’s green light by the Food and Drug Administration “is a big deal because then it opens the door and accelerates technology,” said Michael McCrea, a brain injury expert at Medical College of Wisconsin. The test detects two proteins present in brain cells that can leak into the bloodstream following a blow to ...



Highmark makes moves to reduce opioid abuse

Thu, 15 Feb 2018 16:50:33 +0100

Highmark Inc. will limit its commercial members to an initial seven-day supply of opioid-based medication when first prescribed. The company also plans to expand a program that uses data analysis to help providers cut down on the potential for opioid abuse among patients. The moves were announced Thursday at a news conference held by top executives at the Pittsburgh-based insurer. The restrictions on initial opioid prescr iptions announced Thursday took effect Feb. 1 for its commercial members.… (Source: bizjournals.com Health Care:Biotechnology headlines)



Acorda posts Q4 revenue beat, but misses EPS estimates

Thu, 15 Feb 2018 16:22:41 +0100

Shares in Acorda Therapeutics (NSDQ:ACOR) fell today after the biotech company met sales expectations on Wall Street with its fourth-quarter results, but missed EPS estimates. The Ardsley, N.Y.-based company posted a net loss of -$171 million on sales of $188.4 million for the 3 months ended Dec.31, for sales growth of 34% compared with the same period last year. In explaining the company’s quarterly loss, Acorda cited a $234 million charge associated with the termination of one of its Parkinson’s therapy programs and a $24 million charge linked with a clinical trial that failed to meet key endpoints. Get the full story at our sister site, Drug Delivery Business News. The post Acorda posts Q4 revenue beat, but misses EPS estimates appeared first on MassDevice. (Source: Mass Devi...



Nicole Holst helps build the legal team at Hospital Sisters Health System

Thu, 15 Feb 2018 15:30:00 +0100

Holst leads a three-attorney team based out of HSHS ’s Belleville office that provides legal support for five Illinois hospitals. (Source: bizjournals.com Health Care:Biotechnology headlines)



Florida Hospital plans expansions at 2 local campuses

Thu, 15 Feb 2018 15:27:03 +0100

One of Central Florida's largest employers is ready to grow some more. (Source: bizjournals.com Health Care:Biotechnology headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




EHS files suit against state regulators over order to move patients

Thu, 15 Feb 2018 15:00:25 +0100

Employee Health Systems Medical Group has filed suit against state regulators after nine health plans were ordered to cancel all contracts with the medical group and transfer 600,000 patients to other providers. The company, which does business as EHS, filed the suit Monday in the U.S. District Court for the Central District of California. The suit alleges the California Department of Managed Health Care exceeded its authority when it sent a cease-and-desist order in late December to nine health… (Source: bizjournals.com Health Care:Biotechnology headlines)



Pittsburgh medical device firm bought for $250M

Thu, 15 Feb 2018 14:40:25 +0100

A medical technology company based in London announced an agreement to buy a Pittsburgh firm focused on advanced cardiopulmonary temporary support solutions for $250 million. LivaNova PLC said it is acquiring CardiacAssist Inc., which does business as TandemLife and is based in O’Hara Township. The deal is expected to close by the end of June. LivaNova said upfront costs of the transaction total $200 million, with up to $50 million in contingent considerations based on regulatory milestones. TandemLife’s… (Source: bizjournals.com Health Care:Biotechnology headlines)



Health care costs growing faster than the economy

Thu, 15 Feb 2018 14:30:52 +0100

Increased spending on prescription medications will continue to drive up health care costs faster than the economy grows as Baby Boomers age and the use of expensive specialty drugs rises. Department of Health and Human Services actuaries Wednesday projected health care costs will rise by an average of 5.5 percent annually through 2026, rising from $3.7 trillion to $5.7 trillion in eight years. That’s about 1 percentage point faster than predicted economic growth, Fox Business rep orted.  The… (Source: bizjournals.com Health Care:Biotechnology headlines)



New York lawmakers propose fund that would benefit from Centene/Fidelis deal

Thu, 15 Feb 2018 14:25:44 +0100

Lawmakers in New York state are proposing a fund that would derive most of its revenue from the taxing of the proceeds from converting nonprofit health plans to for-profit systems, such as Centene Corp.'s $3.75 billion acquisition of Fidelis Care. The proposed "health care shortfall fund" would help the state address federal healthcare cuts, Health Leaders Media reports. The fund would collect about $750 million annually for the next four years, likely including about $250 million in annual revenue… (Source: bizjournals.com Health Care:Biotechnology headlines)



Celgene Spinout Celularity Raises $250 Million To Develop Placental Cells To Attack Cancer

Thu, 15 Feb 2018 14:00:00 +0100

Celularity, a company spun out of biotech giant Celgene, announced this morning it has raised $250 million with the aim of developing cells from placentas to attack tumors and to treat Crohn ’s disease. In addition to being awash in cash, the company is flooded with big dreams. (Source: Forbes.com Healthcare News)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




New York lawmakers propose fund that would benefit from Centene/Fidelis deal

Thu, 15 Feb 2018 13:41:04 +0100

Lawmakers in New York state are proposing a fund that would derive most of its revenue from the taxing of the proceeds from converting nonprofit health plans to for-profit system. The proposed "health care shortfall fund" would help the state address federal healthcare cuts, Health Leaders Media reports. The fund would collect about $750 million annually for the next four years, likely including about $250 million in annual revenue from Fidelis Care alone, Health Leaders re ports. St. Louis-based… (Source: bizjournals.com Health Care:Biotechnology headlines)



Dr. Theresa Schwartz revamps cancer care at SLU Hospital

Thu, 15 Feb 2018 13:33:32 +0100

Before Theresa Schwartz arrived as a SLUCare physician and surgeon at SSM Health Saint Louis University Hospital, there wasn ’t extensive programming designated to provide care for women with breast cancer and benign breast diseases at the hospital. (Source: bizjournals.com Health Care:Biotechnology headlines)



Mark Bini leads innovation to help Express Scripts clients lead healthier lives

Thu, 15 Feb 2018 13:30:01 +0100

Mark Bini says that his job is to dream up what many may think is impossible, then prove to the market that not only is it possible, but it ’s scalable for large groups of users. (Source: bizjournals.com Health Care:Biotechnology headlines)



Cambridge biotech startup seeking to repurpose Vioxx raises $5M

Thu, 15 Feb 2018 13:07:40 +0100

Tremeau Pharmaceuticals, a Cambridge biotech startup that is seeking to repurpose the controversial Merck& Co. arthritis drug Vioxx as a treatment for joint pain caused by hemophilia, has closed its first equity round. Tremeau, which was founded last year, announced Thursday that it has raised $5.2 million in equity financing, although it did not disclose the investors that participated. The six-employee company said the funding would be used to advance the drug — whose generic name is rofecoxib… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)



Government to come out with new pharma policy: Ananth Kumar

Thu, 15 Feb 2018 13:03:39 +0100

The big healthcare initiative announced in the budget for 2018-19 seeks to cover 10 crore households requires many verticals -- infrastructure, human resources and pharma and medical device products. (Source: The Economic Times Healthcare and Biotech News)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Government to bring major changes in Drug Pricing Control Order

Thu, 15 Feb 2018 09:32:56 +0100

"We will have major reforms in DPCO, that I am going to assure. We need to have reforms in DPCO. We need to come out with a new pharma policy," Kumar said. (Source: The Economic Times Healthcare and Biotech News)



Developer seeks big expansion at Menlo Park Labs office and R & D campus

Thu, 15 Feb 2018 05:56:02 +0100

The proposals, which together would grow the campus by more than 25 percent, come after the city of Menlo Park agreed to create a new life sciences zoning category that allow higher density development on the site. (Source: bizjournals.com Health Care:Biotechnology headlines)



Hawaii bumped to third in annual State of Well-Being Rankings report

Thu, 15 Feb 2018 01:02:36 +0100

Hawaii is no longer the state with the healthiest residents, in terms of mind and body, according to the most recent State of Well-Being Rankings report released by Gallup and health and wellness engagement platform Sharecare on Tuesday. The Aloha State fell from first to third, edged out by the No. 1 ranked South Dakota and Vermont, which placed second. Hawaii occupied the No. 1 spot for the last two years, a designation it has held for a record six times since Gallup-Sharecare began tracking… (Source: bizjournals.com Health Care:Biotechnology headlines)



Tokyo pharma giant acquires Seattle's Universal Cells for $100M

Thu, 15 Feb 2018 00:12:43 +0100

It's the latest in a string of big biotech acquisitions that is expected to continue throughout the year. (Source: bizjournals.com Health Care:Biotechnology headlines)



Legislative committee backs increase in regulations on free-standing emergency rooms

Thu, 15 Feb 2018 00:04:27 +0100

Republicans and Democrats have teamed with business leaders, insurers and health-care advocates to come up with a solution that received bipartisan support in passing out of its first committee on Wednesday. (Source: bizjournals.com Health Care:Biotechnology headlines)



Biogen shares plunge after company makes change to Alzheimer ’s drug trials

Wed, 14 Feb 2018 23:39:47 +0100

Biogen said Wednesday that it will increase the size of trials of its experimental Alzheimer ’s drug after early data showed “variability” in the data, sending shares of the Cambridge company down sharply. A spokesperson for Biogen (Nasdaq: BIIB) said the company had decided to increase the sample size of two closely watched trials by 510 patients, to a total of 3,210 patients, confi rming remarks by the company’s chief medical officer during a healthcare conference earlier on Wednesday afternoon.… (Source: bizjournals.com Health Care:Biotechnology headlines)



Judge rules for Missouri Hospital Association in suit over hospital payments

Wed, 14 Feb 2018 22:41:02 +0100

A U.S. District judge has ruled in favor of the Missouri Hospital Association in a case regarding how much hospitals in the state receive in disproportionate share allotments from the Centers for Medicare and Medicaid. (Source: bizjournals.com Health Care:Biotechnology headlines)



Oregon health insurance execs opine on Amazon deal, mandate and Measure 101

Wed, 14 Feb 2018 22:01:04 +0100

One CEO said he'll believe that Amazon et al can make a difference when he sees a drone flying into a pharmacy in Baker City. (Source: bizjournals.com Health Care:Biotechnology headlines)



Omeros stock drops as short-seller takes aim

Wed, 14 Feb 2018 21:25:43 +0100

Omeros' stock has fallen about 19 percent after investment adviser FourWorld Capital Management forecast a sharp drop in revenue after Medicare reimbursement ended for its only drug on the market. (Source: bizjournals.com Health Care:Biotechnology headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Rise in uncompensated care doesn't stop Missouri hospitals from hiring, building

Wed, 14 Feb 2018 21:04:57 +0100

Hospitals in the Kansas City area continued to spend capital even with a slight uptick in uncompensated care. (Source: bizjournals.com Health Care:Biotechnology headlines)



Why Merck's Provata acquisition could portend more health care M & A

Wed, 14 Feb 2018 20:47:46 +0100

Look for increased deal activity as investors hunt for promising health IT startups and drugmakers look for ways to reduce overall health care costs as public scrutiny intensifies. (Source: bizjournals.com Health Care:Biotechnology headlines)



Colorado biotech company lands defense contract

Wed, 14 Feb 2018 18:58:17 +0100

“Our goal is to help transform the management of severely ill individuals" (Source: bizjournals.com Health Care:Biotechnology headlines)



Vertex says non-opioid pain drug hits mark in study

Wed, 14 Feb 2018 18:32:53 +0100

Vertex Pharmaceuticals has unveiled promising findings from a study of one of its experimental drugs — only this time, the treatment doesn’t target cystic fibrosis. Boston-based Vertex (Nasdaq: VRTX), which largely focuses on the lung disorder, said Wednesday that its non-opioid medicine for pain had performed well in a mid-stage study. Patients who received the drug, called VX-150, following surgery to remove bunions reported significant pain relief compared to those on placebo, according to… (Source: bizjournals.com Health Care:Biotechnology headlines)



Why a Maryland health system formed a clinical affiliation with UPMC

Wed, 14 Feb 2018 18:23:49 +0100

For UPMC, it's the first affiliation for a hospital in Maryland, an area that CEO Jeffrey Romoff has previously expressed interest in. (Source: bizjournals.com Health Care:Biotechnology headlines)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Baptist Health promotes Patricia Rosello to CEO of largest hospital

Wed, 14 Feb 2018 18:16:56 +0100

Baptist Health South Florida promoted veteran executive Patricia Rosello to CEO of Baptist Hospital, its flagship medical facility. This move was set it motion when Wayne Brackin resigned as Baptist Health chief operating officer in January. Bo Boulenger, the CEO of Baptist Hospital, was then named COO. That opened up a new position for Rosello, who has been CEO of Baptist Outpatient Services since 2003. “Though there were several highly qualified executives considered to serve as my successor… (Source: bizjournals.com Health Care:Biotechnology headlines)



Study: Kansas health care sector generates $25B in sales

Wed, 14 Feb 2018 18:05:32 +0100

Hospitals and health care systems are a key contributor to the Kansas economy.   The state’s health care sector generated $25.7 billion in sales in 2017 and more than $14 billion in income, a new study from the Kansas Hospital Association finds. Hospitals employ 86,324 people statewide, according to the study. That’s more than 4 percent of all job holders in Kansas. Res earchers say the state’s hospitals also account for 75,659 indirect jobs.  Combined, Kansas’ health care industry employs… (Source: bizjournals.com Health Care:Biotechnology headlines)



State gives final approval to Partners' Mass. Eye and Ear acquisition

Wed, 14 Feb 2018 17:34:01 +0100

The state's public health council has approved Partners HealthCare ’s proposed acquisition of Massachusetts Eye and Ear, despite concerns that the deal could dramatically increase health care costs. The unanimous vote on Wednesday, which allows Partners to complete the acquisition, followed a hearing at which representatives for the health system and Mass. Eye a nd Ear sought to assuage concerns that the deal will significantly raise rates. The state’s Health Policy Commission, a health care… (Source: bizjournals.com Health Care:Biotechnology headlines)



Aetna gives $1M grant to N.C. coalition to combat opioid epidemic

Wed, 14 Feb 2018 17:30:39 +0100

The North Carolina Harm Reduction Coalition (NCHRC) is the first recipient of new funding from the Aetna Foundation to address the ongoing opioid epidemic in the U.S. NCHRC will receive a $1 million grant over two years, part of a $6 million national program, from the Aetna Foundation for its Rural Opioid Overdose Prevention Project. Dr. Garth Graham, president of the Aetna Foundation and vice president of Community Health for Aetna, says that NCHRC's focus on rural communities and the need for… (Source: bizjournals.com Health Care:Biotechnology headlines)



Trump budget allots $1.2B for Cerner's VA contract

Wed, 14 Feb 2018 17:14:28 +0100

A fiscal year 2019 federal budget proposed Tuesday by President Donald Trump calls for $1.2 billion for Cerner Corp.'s contract with the Department of Veterans Affairs. VA Secretary Dr. David Shulkin first announced the selection of Cerner (Nasdaq: CERN) for the project in June, but a contract has not yet been signed. The department delayed the contract so that it could conduct an external review to define interoperability, or how the EHR system should communicat e with other systems. Shulkin had… (Source: bizjournals.com Health Care:Biotechnology headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Bristol-Myers signs record biotech partnership deal

Wed, 14 Feb 2018 17:02:19 +0100

Drugmaker to pay Nektar $1.85bn upfront in hope of boosting cancer immunotherapies (Source: FT.com - Drugs and Healthcare)



UMC contract protest questions Mazars' health experience

Wed, 14 Feb 2018 16:54:57 +0100

One of the companies competing to become the next operator of District-owned United Medical Center has filed a protest against the hospital's selection of Mazars USA LLP to oversee its financial turnaround. FTI Health Solutions, a consulting practice of D.C.-based FTI Consulting (NYSE: FCN), claimed in a letter filed Feb. 9 with the D.C. Contract Appeals Board that UMC violated D.C. procurement law when it awarded a $5 million, eight-month contract to New York-based Mazars. The contract is slated… (Source: bizjournals.com Health Care:Biotechnology headlines)



Cincinnati doctor helps firm land defense contract

Wed, 14 Feb 2018 16:35:56 +0100

Dr. Hector Wong ’s research at Cincinnati Children’s Hospital is being credited as key to a biotech firm landing a contract with the U.S. Defense Advanced Research Projects Agency. MBio Diagnostics Inc., a Colorado company that specializes in rapid on-the-spot clinical diagnostics and sample testing, today rev ealed it had been awarded a Phase II DARPA contract.  DARPA focuses on breakthrough technologies for national security, including battlefield medicine to treat wounded U.S. troops. MBio… (Source: bizjournals.com Health Care:Biotechnology headlines)



Bristol-Myers To Pay Largest Fee In Biotech History For Nektar Cancer Drug

Wed, 14 Feb 2018 12:00:00 +0100

Bristol-Myers Squibb says it will pay a record $1.85 billion to Nektar Therapeutics, a small biotech startup, for rights to its experimental cancer drug, codenamed NKTR-214. Nektar will book 65% of global profits on the drug, should it reach the market, with Bristol getting the other 35%. (Source: Forbes.com Healthcare News)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Three UB spinouts score federal funding to pursue healthcare, water purification technologies

Wed, 14 Feb 2018 07:31:37 +0100

Each of the companies – Neurovascular Diagnostics, Ferric Contrast, Sunny Clean Water – received six-figure federal grants to help pursue their startups. (Source: bizjournals.com Health Care:Biotechnology headlines)



Study: Here's why Coloradans pay more for health care

Wed, 14 Feb 2018 03:53:00 +0100

Coloradans pay 17 percent more than residents of other states for their health care — and they partly have themselves to blame, according to a study unveiled Tuesday. The study, which included data gathered from here and four other states, revealed that both higher utilization and higher service costs contributed to the disparity, but found that higher utilization of services wa s the bigger factor among the two. The Center for Improving Value in Health Care contributed data for the study, a… (Source: bizjournals.com Health Care:Biotechnology headlines)



DaVita eyes acquisitions, share buy-backs with cash windfall

Wed, 14 Feb 2018 01:09:36 +0100

Flush with $4.9 billion in cash from the pending sale of its medical group and as much as $130 million in expected benefits from federal tax reform, DaVita Inc. CEO Kent Thiry said Tuesday that the company will look to repurchase shares, grow its kidney-care business and make “a limited number of investments” in other health-care companies. The comments came during a quarterly earnings call — the Denver-based kidney-care provider’s first since it announced the sale of its disappointing managed-care… (Source: bizjournals.com Health Care:Biotechnology headlines)



Kansas grants HCA Midwest $3M in incentives for new HQ

Wed, 14 Feb 2018 00:53:56 +0100

HCA Midwest will receive $3 million in state incentives to move its headquarters four miles west from its south Kansas City location into an Overland Park office park that already is being developed. Last week, the Kansas Department of Commerce announced that the sprawling health system’s administrative unit would move into the office park at the intersection of Intersection 435 and Nall Avenue. Anchor tenant Creative Planning received $6.3 million in incentives to move its headquarters from … (Source: bizjournals.com Health Care:Biotechnology headlines)



Regulators approve Advocate, Aurora health care merger

Tue, 13 Feb 2018 23:07:13 +0100

Aurora Health Care of Milwaukee and Advocate Health Care of suburban Chicago received approval for their planned merger from the main Illinois regulatory agency and the Federal Trade Commission. (Source: bizjournals.com Health Care:Biotechnology headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




New CEO named to oversee CHI St. Luke ’s Health

Tue, 13 Feb 2018 21:34:01 +0100

Colorado-based Catholic Health Initiatives — the parent of Houston-based CHI St. Luke's Health — announced Feb. 13 that T. Douglas Lawson has been named CEO of the health system's southeastern Texas market and senior vice president of the parent company.  He replaces Michael Covert, who announced in June that he would step down in Augu st. When he assumes his new role March 19, Lawson will oversee CHI’s Texas division, which is composed of 16 hospitals across southeastern Texas. In addition… (Source: bizjournals.com Health Care:Biotechnology headlines)



One bill gaining momentum in the Arizona Legislature is giving dentists a toothache

Tue, 13 Feb 2018 21:19:47 +0100

This Senate bill is giving dentists a toothache (Source: bizjournals.com Health Care:Biotechnology headlines)



Why an MBA is a good choice for an M.D.

Tue, 13 Feb 2018 21:12:49 +0100

Early in her career, Dr. Sowmya Viswanathan, former chief ACO officer at Dartmouth-Hitchcock physicians network, discovered a gaping hole in her training. After years of schooling and residency, she was well-prepared to be a physician. But as she moved into leadership roles, she found she needed to know more about the business of healthcare. She said she didn’t know enough about how insurance worked, the management challenges any organization fac es, or business strategy to be as effective as… (Source: bizjournals.com Health Care:Biotechnology headlines)